Controlled double-blind trial of "persantin" in treatment of angina pectoris.
作者信息
FOULDS T, MACKINNON J
出版信息
Br Med J. 1960 Sep 17;2(5202):835. doi: 10.1136/bmj.2.5202.835.
Abstract
摘要
相似文献
1
Controlled double-blind trial of "persantin" in treatment of angina pectoris.“潘生丁”治疗心绞痛的对照双盲试验。
Br Med J. 1960 Sep 17;2(5202):835. doi: 10.1136/bmj.2.5202.835.
2
[Persantin in the treatment of angina pectoris. Double-blind experiment].潘生丁治疗心绞痛。双盲实验
Ugeskr Laeger. 1960 Dec 9;122:1719-20.
3
A controlled clinical trial of 'persantin' (R A 8) in angina pectoris.“潘生丁”（RA 8）治疗心绞痛的对照临床试验。
S Afr Med J. 1961 Jan 7;35:11-3.
4
[Angina pectoris treated with Persantin].用潘生丁治疗心绞痛
Ugeskr Laeger. 1962 Jan 26;124:107-8.
5
A clinical trial of Persantin and Crodimyl in the treatment of angina of effort.潘生丁与克罗地米尔治疗劳力型心绞痛的临床试验。
Scott Med J. 1961 Apr;6:149-52. doi: 10.1177/003693306100600403.
6
A pilot clinical trial of "Persantin".“潘生丁”的一项试点临床试验。
Med J Aust. 1961 Sep 9;48(2):435-6. doi: 10.5694/j.1326-5377.1961.tb69648.x.
7
[Treatment of refractory angina pectoris with a new coronary vasodilator].[用一种新型冠状血管扩张剂治疗难治性心绞痛]
Rev Med Chil. 1961 Aug;89:592-4.
8
[RA-8 in the treatment of angina pectoris].[RA - 8用于治疗心绞痛]
Sem Med. 1960 Oct 13;117:1227-31.
9
10
Treatment of angina pectoris with a new coronary vasodilator, isosorbide dinitrate sublingual (Isordil Subloral).用新型冠状血管扩张剂硝酸异山梨酯舌下片（异舒吉舌下片）治疗心绞痛。
Angiology. 1962 Sep;13:425-34. doi: 10.1177/000331976201300906.
引用本文的文献
1
The dark side of the moon of coronary vasodilation.冠状动脉舒张的阴暗面。
Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1491-2. doi: 10.1007/s00259-016-3416-3.
2
To-day's Drugs.今日的药物。
Br Med J. 1963 Jul 13;2(5349):103-5.
3
Do we still need dipyridamole?我们仍然需要双嘧达莫吗？
Br J Clin Pharmacol. 1998 Apr;45(4):323-8. doi: 10.1046/j.1365-2125.1998.t01-1-00677.x.
4
Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.抗血小板治疗随机试验的协作综述——I：各类患者长期抗血小板治疗预防死亡、心肌梗死和中风。抗血小板试验协作组。
BMJ. 1994 Jan 8;308(6921):81-106.
5
Haemodynamic effects of dipyridamole at rest and during exercise in healthy subjects.双嘧达莫在健康受试者静息及运动状态下的血流动力学效应。
Br Heart J. 1966 May;28(3):331-4. doi: 10.1136/hrt.28.3.331.
6
Controlled trial of dipyridamole in cerebral vascular disease.双嘧达莫治疗脑血管疾病的对照试验。
Br Med J. 1969 Mar 8;1(5644):614-5. doi: 10.1136/bmj.1.5644.614.
7
Antiplatelet agents in coronary disease: are they of prophylactic value?冠心病中的抗血小板药物：它们具有预防价值吗？
Drugs. 1978 Jun;15(6):464-71. doi: 10.2165/00003495-197815060-00004.
本文引用的文献
1
[Persantin, a new substance for therapy of coronary insufficiency].[潘生丁，一种治疗冠状动脉供血不足的新药]
Munch Med Wochenschr. 1959 Feb 20;101(8):340-1.
2
Effect of a pyrimido-pyrimidine derivative on the oxygen supply of the heart muscle.一种嘧啶并嘧啶衍生物对心肌氧供应的影响。
Arzneimittelforschung. 1959 Jan;9(1):49-59.
Zotero 插件